162 related articles for article (PubMed ID: 35697416)
1. Effectiveness and Drug Survival of Apremilast in 65 Patients With Psoriasis and/or Psoriatic Arthritis.
Garbayo Salmons P; Expósito Serrano V; Romaní de Gabriel J; Ribera Pibernat M
Actas Dermosifiliogr; 2022 May; 113(5):532-535. PubMed ID: 35697416
[No Abstract] [Full Text] [Related]
2. ▼ Apremilast for psoriasis and psoriatic arthritis.
Drug Ther Bull; 2015 Sep; 53(9):105-8. PubMed ID: 26358317
[TBL] [Abstract][Full Text] [Related]
3. Apremilast: A Review in Psoriasis and Psoriatic Arthritis.
Keating GM
Drugs; 2017 Mar; 77(4):459-472. PubMed ID: 28213862
[TBL] [Abstract][Full Text] [Related]
4. Apremilast in the treatment of psoriasis and psoriatic arthritis.
Gooderham M; Papp K
Skin Therapy Lett; 2015; 20(5):1-6. PubMed ID: 26382906
[TBL] [Abstract][Full Text] [Related]
5. Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis.
Mavropoulos A; Zafiriou E; Simopoulou T; Brotis AG; Liaskos C; Roussaki-Schulze A; Katsiari CG; Bogdanos DP; Sakkas LI
Rheumatology (Oxford); 2019 Dec; 58(12):2240-2250. PubMed ID: 31209492
[TBL] [Abstract][Full Text] [Related]
6. Safety evaluation of apremilast for the treatment of psoriasis.
Dattola A; Del Duca E; Saraceno R; Gramiccia T; Bianchi L
Expert Opin Drug Saf; 2017 Mar; 16(3):381-385. PubMed ID: 28132578
[TBL] [Abstract][Full Text] [Related]
7. Apremilast efficacy and safety in a psoriatic arthritis patient affected by HIV and HBV virus infections.
Manfreda V; Esposito M; Campione E; Bianchi L; Giunta A
Postgrad Med; 2019 Apr; 131(3):239-240. PubMed ID: 30700196
[TBL] [Abstract][Full Text] [Related]
8. New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast.
Palfreeman AC; McNamee KE; McCann FE
Drug Des Devel Ther; 2013; 7():201-10. PubMed ID: 23569359
[TBL] [Abstract][Full Text] [Related]
9. Drug Survival of Apremilast for Psoriatic Arthritis in a Real-World Setting: A Single-Center Experience.
Foti R; Visalli E; Amato G; Dal Bosco Y; Foti R; Baccano G
J Rheumatol; 2023 Mar; 50(3):458-459. PubMed ID: 36182113
[No Abstract] [Full Text] [Related]
10. Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis.
Gisondi P; Girolomoni G
Drug Des Devel Ther; 2016; 10():1763-70. PubMed ID: 27307707
[TBL] [Abstract][Full Text] [Related]
11. Combination Therapy of Apremilast and Biologic Agent as a Safe Option of Psoriatic Arthritis and Psoriasis.
Metyas S; Tomassian C; Messiah R; Gettas T; Chen C; Quismorio A
Curr Rheumatol Rev; 2019; 15(3):234-237. PubMed ID: 30499418
[TBL] [Abstract][Full Text] [Related]
12. Apremilast Use in Oligoarticular Psoriatic Arthritis.
Torrente-Segarra V; Bonet M
J Rheumatol; 2022 Nov; 49(11):1293-1294. PubMed ID: 35649545
[No Abstract] [Full Text] [Related]
13. Apremilast for the treatment of psoriatic arthritis.
Martin BC; Thomas LW; Dann FJ
Dermatol Online J; 2017 Feb; 23(2):. PubMed ID: 28329487
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Apremilast Therapy on Deployability in Active Duty US Army Soldiers With Plaque Psoriasis and Psoriatic Arthritis.
Price AD; Wagler VD; Donaldson C; Mastin PJ
J Clin Rheumatol; 2021 Apr; 27(3):127-128. PubMed ID: 33136692
[No Abstract] [Full Text] [Related]
15. Drug safety evaluation of apremilast for treating psoriatic arthritis.
Busa S; Kavanaugh A
Expert Opin Drug Saf; 2015 Jun; 14(6):979-85. PubMed ID: 25827658
[TBL] [Abstract][Full Text] [Related]
16. Apremilast Uses and Relevance to the Military.
Hathaway NE; Lyford WH
Cutis; 2021 Apr; 107(4):216-220. PubMed ID: 34096849
[TBL] [Abstract][Full Text] [Related]
17. Safety of Apremilast in Patients with Psoriasis and Psoriatic Arthritis: Findings from the UK Clinical Practice Research Datalink.
Persson R; Cordey M; Paris M; Jick S
Drug Saf; 2022 Nov; 45(11):1403-1411. PubMed ID: 36151359
[TBL] [Abstract][Full Text] [Related]
18. Apremilast: A Novel Drug for Treatment of Psoriasis and Psoriatic Arthritis.
Haber SL; Hamilton S; Bank M; Leong SY; Pierce E
Ann Pharmacother; 2016 Apr; 50(4):282-90. PubMed ID: 26783350
[TBL] [Abstract][Full Text] [Related]
19. Apremilast for the treatment of psoriatic arthritis.
Varada S; Tintle SJ; Gottlieb AB
Expert Rev Clin Pharmacol; 2014 May; 7(3):239-50. PubMed ID: 24702658
[TBL] [Abstract][Full Text] [Related]
20. Apremilast (Otezla). No progress in plaque psoriasis or psoriatic arthritis.
Prescrire Int; 2016 Jun; 25(172):149-51. PubMed ID: 27486641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
